Angiotensin-Converting Enzyme Gene Polymorphism Is Associated with Vulnerability to Alcoholic Cardiomyopathy
- Joaquim Fernández-Solà, MD;
- Josep María Nicolás, MD;
- Josep Oriola, PhD;
- Emilio Sacanella, MD;
- Ramón Estruch, MD;
- Emanuel Rubin, MD; and
- Alvaro Urbano-Márquez, MD
Abstract
Background: Chronic alcohol abuse has a dose-dependent toxic effect on the myocardium, leading to alcoholic cardiomyopathy. The fact that only a minority of persons with chronic alcoholism have this condition suggests the possibility of a genetic vulnerability. In this context, polymorphism of the angiotensin-converting enzyme (ACE) gene has been implicated in cardiac dysfunction.
Objective: To compare the ACE genotypes of alcoholic persons who have cardiomyopathy with those of comparable alcohol abusers who have normal cardiac function.
Design: Case–control study over a 2-year period.
Setting: An academic tertiary referral hospital in Barcelona, Spain.
Patients: 30 alcoholic men with symptomatic cardiomyopathy and 27 alcoholic men with normal cardiac function.
Measurements: Ethanol intake, cardiac status, left ventricular ejection fraction (LVEF), and ACE gene polymorphism.
Results: The DD ACE genotype was present in 57% of alcoholic persons with an LVEF less than 0.50 and in 7% of those with normal cardiac function. Compared with persons who had an I allele, the odds ratio for development of left ventricular dysfunction in alcoholic persons with the DD genotype was 16.4.
Conclusions: Vulnerability to cardiomyopathy among chronic alcohol abusers is partially genetic and is related to presence of the ACE DD genotype. This finding demonstrates genetic susceptibility to alcohol-induced myocardial damage.
Article and Author Information
-
Grant Support: By Fondo de Investigación Sanitaria (grants 98/0330, 99/0115, and 99/0318) and Generalitat de Catalunya (grant CUR 2001/SGR/00379).
-
Requests for Single Reprints: Emanuel Rubin, MD, Department of Pathology, Anatomy, and Cell Biology, Jefferson Medical College, 1020 Locust Street, Suite 279, Philadelphia, PA 19107; e-mail, emanuel.rubin{at}mail.tju.edu.
-
Potential Financial Conflicts of Interest:Grants Received: J. Fernández-Solà, J.M. Nicolás, E. Sacanella, R. Estruch, A. Urbano-Márquez.
-
Current Author Addresses: Drs. Fernández-Solà, Nicolás, Oriola, Sacanella, Estruch, and Urbano-Márquez: Alcohol Research and Cardiac Units, Department of Medicine, Hospital Clínic i Provincial, University of Barcelona, Villaroel, 170 08036, Barcelona, Spain.
-
Dr. Rubin: Department of Pathology and Cell Biology, Jefferson Medical College, Thomas Jefferson University, 1020 Locust Street, Suite 279, Philadelphia, PA 19107-6799
-
Author Contributions: Conception and design: J. Fernández-Solà, J. María Nicolás, E. Rubin, A. Urbano-Márquez.
-
Analysis and interpretation of the data: J. Fernández-Solà, J. María Nicolás, E. Rubin.
-
Drafting of the article: J. Fernández-Solà, J. María Nicolás, E. Rubin, A. Urbano-Márquez.
-
Critical revision of the article for important intellectual content: E. Rubin
-
Final approval of the article: A. Urbano-Márquez.
-
Provision of study materials or patients: E. Sacanella, R. Estruch.
-
Statistical expertise: J. María Nicolás.
-
Obtaining of funding: J. Fernández-Solà, J. María Nicolás, R. Estruch, E. Rubin.
-
Administrative, technical, or logistic support: J. Oriola.
-
Collection and assembly of data: E. Sacanella.
- Copyright ©2004 by the American College of Physicians
RSS Feeds









